Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.64% |
| Jun 30, 2025 | -160.00% |
| Dec 31, 2024 | 99.77% |
| Sep 30, 2024 | 99.72% |
| Mar 31, 2024 | 99.88% |
| Sep 30, 2023 | -70,215.91% |
| Sep 30, 2022 | -94.12% |
| Sep 30, 2021 | 99.32% |
| Mar 31, 2021 | -238.22% |
| Sep 30, 2020 | -298.35% |
| Mar 31, 2020 | -52.15% |
| Dec 31, 2019 | 123.85% |
| Sep 30, 2019 | -33.39% |
| Jun 30, 2019 | -100.41% |
| Mar 31, 2019 | 132.81% |
| Dec 31, 2018 | 23,165.63% |
| Sep 30, 2018 | 25,492.94% |
| Jun 30, 2018 | -280,642.10% |
| Mar 31, 2018 | -95,985.96% |
| Dec 31, 2017 | -89.63% |
| Sep 30, 2017 | -101.36% |
| Jun 30, 2017 | -100.21% |
| Mar 31, 2017 | 49.45% |
| Dec 31, 2016 | 1,061.82% |
| Sep 30, 2016 | 5,050.75% |
| Jun 30, 2016 | 2,611.28% |
| Mar 31, 2016 | -51.54% |
| Dec 31, 2015 | 664.43% |
| Sep 30, 2015 | -395.00% |
| Jun 30, 2015 | 100.31% |
| Mar 31, 2015 | -103.42% |
| Dec 31, 2014 | 99.87% |
| Sep 30, 2014 | 100.36% |
| Jun 30, 2014 | -595.22% |
| Mar 31, 2014 | -14.83% |
| Dec 31, 2013 | 51.56% |
| Sep 30, 2013 | -419,731,500.00% |
| Jun 30, 2013 | 106,508.16% |
| Mar 31, 2013 | 29,919.51% |
| Dec 31, 2012 | -801.98% |
| Sep 30, 2012 | 99.95% |